Morgan Stanley Ignores Einhorn, Remains Positive On Athenahealth, IncMark Melin
Nearly seven days after David Einhorn announced his short attack on Athenahealth, Inc (NASDAQ:ATHN), a Morgan Stanley report doesn't mention the incident in its May 12 research note on the stock.
Athenahealth: Morgan "overweight," notes potential for cost savings in sales, R&D
The report, which has Athenahealth, Inc (NASDAQ:ATHN) as an “overweight” in the portfolio, noted that “Steady state margins reflect the underlying earnings power of . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.